ABSTRACT Patients who have systemic lupus erythematosus have increased numbers of chromosome breaks and rearrangements correlated with a low molecular weight chromosome-damaging agent that is released from their lymphocytes into the serum. This clastogenic factor also produces chromosome breaks and sister chromatid exchanges in healthy persons' lymphocytes when they are incubated in the presence oflupus patients' serum or lymphocytes or purified factor. The lymphocytes from lupus patients are sensitive to near-UV (360-to 400-nm light. This sensitivity seems to be related to the presence of the clastogenic factor in these cells; lymphocytes of healthy persons exposed to the factor also become sensitive to light of the same wavelengths. A significant increase in nonviable cells (trypan blue exclusion test) was observed after 5 min of irradiation with 360-to 380-nm light in the presence of the factor. The number of chromosome aberrations observed after stimulation of the irradiated lymphocytes with phytohemagglutinin was also maximal after irradiation at 380 nm in presence of the factor. The combined action of near-UV light plus clastogenic factor was inhibited by superoxide dismutase if the enzyme were present during irradiation, suggesting that activation involves photoproduction of superoxide ions. Irradiation of the purified factor and immediate addition of it to lymphocytes gave the same results whereas preirradiation ofcells or of medium was without effect. The presence of this photoactivated agent explains why patients who have lupus erythematosus show an aggravated condition after exposure to sunlight and the appearance of typical skin lesions.
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Genetic, immunological, and viral factors are involved in the origin ofsystemic lupus erythematosus (SLE), considered as the prototype of human autoimmune disease. Lupus patients are photosensitive and develop a facial rash, the typical "butterfly lesion," after exposure to sunshine. The systemic manifestations of the disease are also aggravated by sunlight. SLE has been claimed to be a DNA-repair-deficiency disease by Beighlie and Teplitz (1), but this is contested by others (2, 3). We here present data that could provide another explanation for the photosensitivity of lupus patients.
Previous work in our laboratory has shown that many human diseases involving autoimmune reactions and also-the murine autoimmune disease of New Zealand black mice are'accompanied by chromosomal instability (4-7). The increase in chromosome breaks and rearrangements in patients who have lupus erythematosus (8) and progressive systemic sclerosis (9) , as well as in New Zealand black mice (10) , is correlated with a < 10,000-dalton chromosome-breaking agent. This clastogenic factor (CF) also produces chromosomal breakage and an increase in sister chromatid exchanges in healthy persons' lymphocytes when they are incubated in the presence of patients' serum or the purified clastogenic agent. The exact nature of the CF is not yet determined, but the breakage phenomenon seems to be related to the generation of activated oxygen species because superoxide dismutase prevents the production of chromosome damage (7) (8) (9) (10) (11) . We have generated the superoxide anion radical O2' photochemically in the culture medium by adding flavin mononucleotide and irradiating with 365-nm light. This method consistently gave an increase in chromosome breaks and rearrangements in blood cultures from healthy subjects, individual results being 20-25 aberrations per 100 mitotic figures. t When we attempted to use this method to study the influence of 02 in blood cultures of lupus patients, the cultures did not grow. Light alone did not significantly increase the aberration rate in blood cultures from healthy persons at the doses used but inhibited growth of blood cultures from SLE patients. This observation prompted us to study in detail the photosensitivity of lymphocytes from SLE patients. The results confirm that, in contrast to normal lymphocytes, SLE lymphocytes are sensitive to 360-to 400-nm light. This sensitivity seems to be related to the presence of the CF in these cells; when exposed to the purified factor, lymphocytes of healthy subjects become sensitive to UV light of the same wavelengths.
MATERIAL AND METHODS
The criteria of the American Rheumatology Association were adopted for diagnosis in the seven SLE patients studied. Therapeutic agents that could produce chromosome damage had not been administered. The blood samples were obtained before x-ray investigations.
Healthy blood donors were recruited among the laboratory and hospital personnel.
The degree of chromosomal instability was studied on blood cultures from SLE patients, and the clastogenic activity of their sera was determined on blood culture preparations from healthv donors. The aberration rate in the cultures exposed to the CF was compared with that in simultaneous untreated cultures from the same person. All cultures were set up in duplicate.
The CF used was prepared as described (8) : An ultrafiltrate of serum from SLE patients was obtained by filtration through Diaflo filter UM 10. Because the clastogenic agent is retained by filter UM 2, this filter was used for concentration of the UM 10 ultrafiltrate. The concentrated ultrafiltrates from several patients were pooled and further purified by Sephadex gel filtration. The clastogenic effect of the purified fractions was tested on blood cultures from healthy donors. Because the activity varied among the patients, different quantities ofthe pooled CF Abbreviations: SLE, systemic lupus erythematosus; CF, clastogenic factor; Pi/NaCl, phosphate-buffered saline; SOD, superoxide dismutase.
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samples were tested to determine the quantity that would produce a significant increase in aberrations but not be toxic enough to prevent culture growth. These quantities were 5-10% of the culture medium. Table 1 . In all seven patients, an increase in nonviable cells was observed after irradiation of the lymphocytes with monochromatic light for 10 min. The maximum number of stained cells was observed at 360-400 nm (peak -380 nm).
After irradiation with near-UV light, the lymphocytes of three patients were incubated for 3 days for cytogenetic analysis. Irradiation at 320 nm had no effect and the aberration rate was the same as in the nonirradiated culture; however, at longer wavelengths (360-400 nm), culture growth was poor and, at 360 nm, the breakage rate was increased significantly [e.g., from 24% to 34% (patient E) and from 26% to 42% (patient F)].
When lymphocytes from healthy persons were irradiated in the presence of the CF, an increase in nonviable cells was observed after 5 (Table 3 ). The aberration rate in these cul- Similar results were obtained when purified CF was irradiated in PJ/NaCl and then added to the cells in culture (Table   5 , cultures 1 and 2) where, again, the presence of SOD in the culture medium was strongly inhibitory (17.1 --3.1, 11.4 -* 0 aberrations per 100 mitotic figures). The increase in activity of the CF by irradiation in PJ/NaCl is also shown for these cultures; activation by irradiation at 380 nm is clearly inhibited by SOD (cultures 1, 2, 3, and 4, in which the SOD present during the irradiation was removed by filtration through UM 10; see control). Doubling the quantity of CF increased the number of aberrations in the absence of irradiation but was lethal after 5 min ofirradiation at 380 nm. Inhibition ofthe unirradiated factor by SOD by using twice as much factor per culture is shown in cultures 5 and 6. DISCUSSION The results of our study, in which monochromatic light at different wavelengths was used, confirmed that lymphocytes from SLE patients are sensitive to 360-to 400-nm light. The next step was to study the influence of monochromatic light on normal lymphocytes in the presence of the CF from lupus patients. Again, the dye-exclusion test showed a maximum of nonviable cells at 360-380 nm. Simultaneously, cytogenetic analysis ofthe surviving lymphocytes showed a considerable increase in the activity of the CF. We may assume that the CF is responsible for the photosensitivity of SLE lymphocytes containing and releasing this agent. The effects of UV light and the CF were not additive; a considerable increase in chromosome damage beyond that produced by the CF alone was observed only if the CF was present during irradiation. Preirradiation of the medium or the cells had no enhancement effect when the CF was added later. However, the increase in clastogenic activity shown by cells both irradiated and exposed to the CF was also obtained if the CF was preirradiated and immediately added to the cells. This shows unequivocally that the increased activity is due to photoactivation of the CF rather than to action by the CF as a photosensitizer for energy transfer to the cell. The protector effect of SOD is indirect evidence that the specific substrate for this enzyme, theO2°radical, plays a role. SOD prevented chromosome damage only ifit was present during exposure and not if it was added 30 min later. This shows that protection is due to scavenging of the toxic radicals, not to repair of the damage. It appears that the CF itself is photosensitive and gives rise to the production of 02, which then reacts with and activates the factor. Photoactivation of the factor via 02 is strongly inhibited by SOD (see Table 5 ). The clastogenic action of the activated factor is also inhibited by SOD. In the absence of irradiation, SOD can also protect the cells against higher doses of the CF, probably because some activation occurs by normal cellular production of O2. It is thus clear that extracellular SOD protects by inhibition of the activation of the CF and also by inhibition of the clastogenic process, which presumably involves production of 02' (or derived HO-radicals) by the activated factor. Given that exogenous (probably membranebound) SOD can inhibit perinuclear halo formation (12) , it appears that extracellular (or membrane-bound) SOD can influence intracellular events.
We have found that the CF is a small molecule (Mr 1000-10,000) and resistant to proteases. Its activity is destroyed by heating to 50'C but conserved over long periods at -300C. The CF does not inhibit SOD; indeed, the oxidation of luminol by the hypoxanthine-xanthine oxidase system is doubled in the presence of the CF, suggesting an increased production of 02 (or other reactive species). It is possible that the photoactivated form is an unstable hydroperoxide formed in vivo in the absence of irradiation by the action of cellular-produced O2'; clastogenic activity is inhibited in both cases by SOD. The presence of an activated oxygen species producing DNA damage is also suggested by the fact that perinuclear halo formation in human fibroblasts resulting from irradiation at 365 nm is completely inhibited if the cells are pretreated with SOD (12).
Beighlie and Teplitz (1) have claimed that SLE might be a DNA-repair-deficiency disease. They observed a decreased unscheduled DNA synthesis in lymphocytes of SLE patients after exposure to 254-nm light, but repair synthesis in SLE fibroblasts was normal. Cleaver (2) concluded that SLE patients are not deficient in DNA repair mechanisms. This study suggests that the DNA lesions in SLE patients are not due to deficient repair but rather are the result of excessive damage induced by a diffusable clastogenic and sister chromatid-inducing agent, the action of which is increased by light at 360-380 nm.
Most of the solar radiation reaching the earth is in the IR, visible, and near-UV regions; far-UV wavelengths (200-300 nm) are almost completely absorbed by the ozone layer in the stratosphere. Ozone concentration and other atmospheric conditions, the sun's zenith angle, the altitude above sea level, and other factors make the destructive effects ofsunlight highly variable. The presence ofa photoactivated clastogenic agent in SLE patients provides an explanation ofwhy these subjects are sensitive to sunlight and show an aggravation oftheir condition after exposure and appearance of typical skin lesions for which the use of sunscreens has been recommended.
